Immunitybio, Inc. · NASDAQ:IBRX
Selecky Christobel sold 96,722 Immunitybio, Inc. shares (Form 4)
Traded Jun 29 to Jun 30, 2026 · Filed Jul 1, 2026
From Jun 29 to Jun 30, 2026, Selecky Christobel (Director) sold 96,722 Immunitybio, Inc. shares at an average US$9.01 for US$871K under a trading plan, leaving 0 shares. Filed Jul 1, 2026 (Form 4).
- Sold
- 96,722 shares
- Price
- US$9.01 average (US$9.00 to US$9.01)
- Value
- US$871K
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | Option exercise | 32,173 | US$2.98 | 32,173 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 33,549 | US$2.99 | 65,722 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 30,000 | US$2.84 | 95,722 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 95,722 | US$9.01 | 0 | Direct |
| Jun 30, 2026 | Common Stock | Option exercise | 700 | US$2.98 | 700 | Direct |
| Jun 30, 2026 | Common Stock | Option exercise | 300 | US$2.99 | 1,000 | Direct |
| Jun 30, 2026 | Common Stock | Sale | 1,000 | US$9.00 | 0 | Direct |
Source
Related
- Immunitybio, Inc.
- Selecky Christobel
- Immunitybio, Inc. shareholders
- Form 4 · Selecky Christobel · Jul 6, 2026
- Form 4 · Simon Barry J. · Oct 6, 2026
- Form 4 · Cohen Cheryl · Oct 6, 2026
- Schedule 13D/A · Cambridge Equities, LP · Aug 6, 2026
- Form 4 · Cohen Cheryl · Jul 6, 2026
- Form 4 · Simon Barry J. · Jun 26, 2026